The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians ...

President Donald Trump has his sights set on drug cartels, according to his administration. A memo was sent by the Trump administration to Congress Thursday. The memo stated the United States is now ...

President Donald Trump speaks in the Oval Office of the White House, Tuesday, Sept. 30, 2025, in Washington. (Alex Brandon/AP) President Donald Trump has declared drug cartels to be unlawful ...

The largest U.S. military deployment in the Caribbean in decades is striking at the heart of Venezuela’s Cartel de los Soles, a criminal network embedded within Nicolás Maduro’s regime and accused of ...

The FDA has issued a manufacturing-related complete response letter for Cyprium Therapeutics’ copper histidinate drug candidate CUTX-101, raising a roadblock on the path to commercializing the first ...

President Donald Trump and the pharmaceutical giant Pfizer announced an agreement Tuesday to lower medication costs for Medicaid patients, advancing Trump’s “Most Favored Nation” pricing effort to ...

The Trump administration is hinting at an upcoming rule aimed at implementing the President’s “most favored nation” drug pricing policy. The proposed policy is titled “global benchmark for efficient ...

This study reviewed all industry-sponsored phase I clinical trial protocols activated at one of eight Sarah Cannon Research Institute drug development units between 2021 and 2024. The review focused ...

The Trump administration confirmed to GOP state attorneys general that the Department of Health and Human Services (HHS) is reviewing the safety protocols for the abortion drug mifepristone. In a ...

WASHINGTON — When President Donald Trump’s administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts — including the ...